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Abstract: Objective: Previous studies have demonstrated that hypertensive waist (HTW) can be 
useful for the screening of metabolic syndrome (MetS) in general population. The objective of this 
study was to compare the ability of HTW and of MetS to predict moderate and high cardiovascular 
risk (CVR). Patients and Method: 1294 persons from the general population of Cluj County have 
been enrolled in the study. Blood samples in fasting state have been withdrawn for measuring of 
blood glucose, total and HDL-cholesterol and serum triglycerides. HTW was defined as 
concomitant presence of a systolic blood pressure of ≥ 130 mmHg and/or a diastolic blood 
pressure of ≥ 85 mmHg or personal history of hypertension plus an abdominal circumference of  ≥ 
80 cm in females and ≥ 94 cm in males. MetS was diagnosed based on International Diabetes 
Federation criteria. CVR was estimated with Framingham Risk Score. Results: The prevalence of 
HTW was 43.3%, and the prevalence of MetS was 45.7%. High CVR was prevalent in 32.4% of 
persons with MetS and in 36.1% of those with HTW. The sensitivity and specificity of HTW to 
predict moderate and high CVR were higher than for MetS (62.9% versus 52.3%, and 67.1% versus 
61.4%). Aria under the receiver operating curve (aROC) was higher for the HTW than for MetS. 
Conclusion: The use of HTW is a valuable method to screen for moderate and high CVR in the 
general population. 
Keywords: Metabolic syndrome; Cardiovascular risk; Waist circumference.  
Introduction 
Recent data published by International Diabetes Federation (IDF) reported a prevalence of the 
metabolic syndrome in the general population ranging from 16% to 37%, according to the set of 
criteria used to define metabolic syndrome and of the population in which such data has been 
obtained [1]. The metabolic syndrome is nowadays considered as one of the most important 
determinants of cardiovascular morbidity and mortality in developed and developing countries. A 
recent meta-analysis of large-scale epidemiological studies demonstrated that the presence of 
metabolic syndrome increases total mortality with 27-37% and cardiovascular disease (CVD) risk 
with 65-93% [2]. Due to high prevalence in the general population, extended and continuous 
screening for metabolic syndrome represents the best method to identify these high-risk individuals 
but this would imply that a large number of subjects should be screened. Therefore, we consider 
that a pre-screening test such as „hypertensive waist” is useful in this case [3]. Hypertensive waist is 
defined as the concomitant presence of high abdominal circumference and systemic hypertension 
and can be used as a first-step method to screen for metabolic syndrome based on two easy-to-
measure parameters.  In each individual with hypertensive waist, measurement of blood glucose, 
serum triglycerides and HDL-cholesterol should be performed to identify all diagnostic criteria of 
metabolic syndrome (Figure 1). NITA Cristina, RUSU Adriana, BALA Cornelia, HÂNCU Nicolae 
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Figure 1. Stepwise screening for metabolic syndrome using hypertensive waist [3] 
 
Previous studies have demonstrated that hypertensive waist is a frequent combination in 
persons with metabolic syndrome and can be useful for the screening of metabolic syndrome in 
general population, having a high specificity and sensitivity, and high positive and negative 
predictive [4]. The objective of this study is to compare the ability of hypertensive waist and of 
metabolic syndrome to predict moderate and high cardiovascular risk based on Framingham Risk 
Score. 
Material and Method 
All employees of two companies in Cluj-Napoca and all persons ≥18 years of age from a rural 
area in Cluj County were invited to participate in the study. Individuals with diabetes were not 
included. A total of 2928 persons gave their informed consent and were included in the study from 
October 2002 to November 2003. Fasting blood samples were obtained for measurement of blood 
glucose, total and HDL-cholesterol and serum triglycerides. LDL-cholesterol was calculated using 
Friedewald equation. Hypertensive waist was defined as concomitant presence of a systolic blood 
pressure of ≥ 130 mmHg and/or a diastolic blood pressure of ≥ 85 mmHg or personal hystory of 
treated hypertension and the presence of an abdominal circumference of  ≥ 80 cm in females and ≥ 
94 cm in males. Metabolic syndrome was diagnosed based on International Diabetes Federation set 
of criteria. Based on preexisting published data in which the prevalence of hypertensive waist was 
around 30% in the Romanian population [5], we calculated that the sample should include 1294 
subjects for a 95% confidence interval (95% CI) ± 5% around a prevalence of 30%. In this report, 
only data from subjects with a complete physical examination and biochemical profile has been 
included. 
Cardiovascular risk was calculated with Framingham Risk Score, a score recommended for non-
diabetic population [6, 7]. Risk stratification according to the risk score was: < 10% low risk, 10-
20% moderate risk, ≥ 20% high risk. 
Statistical analysis was performed using the software SPSS for Windows version 15.0. 
Distribution of variables was tested with Kolmogorov- Smirnov test. Statistical data is presented as 
mean ± standard deviation for normally-distributed variables, median (1st quartile; 3rd quartile) for 
variables with abnormal distribution and percentage for categorical variables. Student t-test was 
used to compare variables with normal distribution, and Mann-Whitney U test for variables with 
abnormal distribution.  Chi-square test was used to compare frequencies. A two-tailed p value≤ 
0.05 was considerred statistically significant. The ability of hypertensive waist and of metabolic 
syndrome to predict moderate and high cardiovascular risk were compared by receiver operating 
characteristics (ROC), and by specificity and sensitivity values. 
HYPERTENSIVE 
Abdominal circumference
≥ 80 cm in female, ≥ 94cm in male 
Blood pressure ≥ 130/85 mmHg 
↓ HDL ↑triglycerides ↑ blood 
METABOLIC SYNDROME
Pre-screening
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Results 
Current report evaluated 756 women and 538 men, with a mean age of 49.1 ± 16.0 years for 
whom complete clinical and biochemical data was available. The prevalence of hypertensive waist 
was 43.3%, and of metabolic syndrome 45.7%. Among individuals with hypertensive waist, 85% 
had metabolic syndrome (Table 1). 
Table 1. Prevalence of hypertensive waist in persons with and without metabolic syndrome 
Hypertensive waist  Metabolic syndrome 
No- n (%) Yes- n (%)
Total 
- n (%) 
Yes   116 (15.8)  476 (85.0) 592  (45.7)
No 618  (84.2)  84  (15.0) 702  (54.3)
 
Characteristics of individuals with hypertensive waist, with or without metabolic syndrome are 
presented in Table 2. Individuals with hypertensive waist but without metabolic syndrome are more 
frequently males, have younger age, lower BMI, lower blood pressure values, lower values of lipids 
and blood glucose levels and have less frequently ischemic heart disease and a lower level of 
sedentary lifestyle. 
Table 2. Characteristics of individuals with hypertensive waist, with or without metabolic 
syndrome 
Metabolic syndrome   
Yes No 
p 
Sex
§  Female (%) 
Male (%) 
91.3 
72.0
8.7 
28.0 
<0.001 
<0.001 
Age (years)  58.2±12.3 54.7±13.6  0.009 
Body weight (kg)  78.1±13.9 78.2±13.7 0.95 
Abdominal circumference (cm) 97.9±10.3 96.7±8.7  0.34 
BMI (kg/m²)  28.6±4.2 27.1±3.0  <0.001 
SBP (mmHg)  151.3±20.5 138.9±13.9 <0.001 
DBP (mmHg)  91.1±11.9 82.8±8.3 <0.001 
Total cholesterol (mg/dl) 203.4±44.0 176.1±50.4  <0.001 
HDL-cholesterol (mg/dl)*  47.2 (43.0 ; 47.2) 43.0 (43.0 ; 47.2)  <0.001 
LDL-cholesterol (mg/dl) 124.3±39.0 114.7±41.0  0.04 
Serum triglycerides (mg/dl)*  148 (104.0 ; 200.5) 103.5 (82.5 ; 127.5)  <0.001 
Fasting blood glucose (mg/dl)* 106.0  (99.0  ;117.0) 96.0  (92.0 ; 99.0)  <0.001 
Personal history of ischemic heart disease (%)§ 32.8 11.9 <0.001 
Low level of physical activity (%)§ 63.4 52.4  0.01 
Data are presented as mean ± standard deviation for normally-distributed variables; 
*median (1st quartile;3rd quartile) for continuous variables with abnormal distribution; 
§ - % for categorical variables 
BMI = body mass index;  
SBP = systolic blood pressure; 
DBP = diastolic blood pressure. 
 
The prevalence of low, moderate and high cardiovascular risk in subjects with metabolic 
syndrome and with hypertensive waist is displayed in Figure 2.  
The two receiver operating characteristics (ROC) curves for hypertensive waist and metabolic 
syndrome in subjects with high cardiovascular risk (≥ 20%) are super imposable (Figure 3), the two 
conditions having equal sensitivity and specificity values (table 3). 
Hypertensive waist had a higher value in predicting moderate and high cardiovascular risk (≥ 
10%) compared with the metabolic syndrome, with higher sensitivity and specificity values (62.9% 
versus 59.3% and 67.1% versus 61.4%) (Figure 4, Table 4). 
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Figure 2. Prevalence of cardiovascular risk categories in subjects with metabolic syndrome and 
with hypertensive waist 
Table 3. Sensitivity and specificity for hypertensive waist and metabolic syndrome in subjects with 
high cardiovascular risk (≥ 20%) 
  aROC (95%CI) Sensitivity (%) Specificity (%) 
Hypertensive waist  0.68 (0.64-0.71)  71.8  63.5 
Metabolic syndrome  0.66 (0.62-0.69)  71.4  60.3 
aROC- area under the receiver operating curve 
 
 
Figure 3. The ability of hypertensive waist and metabolic syndrome to predict high cardiovascular 
risk (≥ 20%) 
Odds ratio (OR) for high cardiovascular risk (≥ 20%) is 4.42 (95%CI: 3.26 – 5.98) in the 
presence of hypertensive waist and 3.79 (95%CI: 2.80 – 5.12) in the presence of metabolic 
syndrome. The same results were obtained for moderate and high cardiovascular risk (OR: 3.44 
[95%CI 2.71 – 4.37] versus OR: 2.31[95%CI:1.83 – 2.82]). 
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Figure 4. The ability of hypertensive waist and metabolic syndrome to predict moderate and high 
cardiovascular risk (≥ 10%) 
Table 4. Sensitivity and specificity for hypertensive waist and metabolic syndrome in subjects with 
moderate and high cardiovascular risk (≥ 10%) 
  aROC (95%CI) Sensitivity (%) Specificity (%) 
Hypertensive waist  0.65 (0.62–0.68) 62.9  67.1 
Metabolic syndrome  0.60 (0.57-0.64)  59.3  61.4 
aROC- area under the receiver operating curve 
Discussion 
Metabolic syndrome is associated with an increased risk of type 2 diabetes and cardiovascular 
diseases [8, 9]. Although there is a debate surronding the concept of metabolic syndrome [10, 11], it 
is recognized as a major and prevalent cardiovascular risk factor by bodies as the World Health 
Organization (WHO) [12], the National Cholesterol Education Program-Adult Treatment Panel III 
(NCEP-ATP III) [7] and International Diabetes Federation (IDF) [13]. The IDF recommendations 
reflects the fact that obesity is a sine qua non component of the metabolic syndrome and together 
with insulin resistance might be one of the underlying causes of the metabolic syndrome [13]. It is 
established that waist circumference  predicts increased risk of morbidity and mortality beyond that 
explained by BMI alone [14, 15]. Several organizations currently advocate for the measurement of 
waist circumference in clinical practice. However, a recent consensus from the ADA, the Obesity 
Society and the American Society for Nutrition questioned the clinical utility of waist circumference 
measurement [16]. The concept of hypertensive waist was proposed by us in 2004 [3] as a simple to 
use tool for the screening of the metabolic syndrome. When, in 2005,  IDF established the new 
criteria for the diagnosis of the metabolic syndrome, hypertensive waist become even more 
appropriate for its specific purpose. The current study aimed to investigate whether hypertensive 
waist could be use to predict moderate and high cardiovascular risk based on Framingham Risk 
Score. The rationale was that the common cardiometabolic risk factors are not assessed in all the 
clinical settings in our country due to lack of personal and resources. In this case we often need to 
find a simple  way to evaluate the cardiovascular risk of the patients in order to make the optimal 
clinical management decisions. The specificity and sensitivity of the hypertensive waist to predict 
moderate and high cardiovascular risk was even higher than those for the metabolic syndrome. 
Moreover, it is very simple to be applied and totally unexpensive, so it can be use to screen for the 
high cardiovascular risk individuals in all clinical settings. 
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Conclusions 
Hypertensive waist has a higher predictive value for moderate and high cardiovascular risk in 
general population compared with that of the metabolic syndrome. The practical importance of this 
finding is that the association of two easy-to-measure parameters (systolic blood pressure ≥ 130 
mmHg and/or diastolic blood pressure ≥ 85 mmHg or the presence of systemic hypertension plus 
an abdominal circumference ≥ 80 cm in female and ≥ 94 cm in male) can be used as an efficient 
screening method to identify individuals with moderate and high cardiovascular risk from the 
general population. Identification of the hypertensive waist will be followed by a detailed screening 
for all the others cardiovascular risk factors and of metabolic syndrome in order to properly 
manage the cardiometabolic risk  
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